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Abstract: Renal hypoxia has recently been implicated as a key contributor and indicator of various
glomerular diseases. As such, monitoring changes in renal oxygenation in these disorders may
provide an early diagnostic advantage that could prevent potential adverse outcomes. Blood oxygen
level-dependent magnetic resonance imaging (BOLD MRI) is an emerging noninvasive technique for
assessing renal oxygenation in glomerular disease. Although BOLD MRI has produced promising
initial results for the use in certain renal pathologies, the use of BOLD imaging in glomerular diseases,
including primary and secondary nephrotic and nephritic syndromes, is relatively unexplored. Early
BOLD studies on primary nephrotic syndrome, nephrotic syndrome secondary to diabetes mellitus,
and nephritic syndrome secondary to systemic lupus erythematosus have shown promising results to
support its future clinical utility. In this review, we outline the advancements made in understanding
the use of BOLD MRI for the assessment, diagnosis, and screening of these pathologies.
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1. Introduction
Glomerular disease continues to be a large health burden worldwide, often occurring
as a primary process or as secondary to systemic inflammatory conditions, infections, and
diabetes mellitus [1]. In the past 10 years, multiple studies have implicated renal hypoxia
in glomerular disease [2–4]. These studies indicate that patients with glomerular disease
exhibit significant decreases in both renal blood flow and oxygenation, possibly due to
basement membrane thickening and extracellular collagen deposition in the mesangium [5].
In order to reduce potential adverse outcomes, monitoring renal hypoxia may establish an
early diagnosis and even help monitor disease progression. A novel noninvasive method
currently being investigated for such purposes is blood oxygenation level-dependent magnetic resonance imaging (BOLD MRI), a functional MRI (fMRI) technique that can evaluate
organ function on the basis of differences in the magnetic properties of deoxyhemoglobin
and hemoglobin. BOLD MRI operates by detecting the differing paramagnetic spin states of
deoxyhemoglobin versus oxyhemoglobin. Increasing amounts of deoxyhemoglobin induce
an internal magnetic field and phase dispersions of neighboring spin states, which ultimately distorts the MRI signal. These results are reported as the R2* (sec−1 ) value, which is
the apparent relaxation rate and indicates the relative content of deoxyhemoglobin. Higher
R2* values are inversely correlated with tissue oxygenation and vice versa. For example,
tissue areas receiving increased blood flow have a decreased proportion of deoxygenated
hemoglobin, and thus, a lower apparent relaxation rate R2*.
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and vice versa. For example, tissue areas receiving increased blood flow have a decreased
proportion of deoxygenated hemoglobin, and thus, a lower apparent relaxation rate R2*.
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2. Primary Nephrotic Syndrome
Primary nephrotic syndrome (PNS) is a collection of symptoms that result from
glomerular basement membrane damage, leading to shared features of proteinuria, hyperlipidemia, hypercoagulability, hypogammaglobulinemia, and hypoalbuminemia. Causes
of PNS include minimal change disease (MCD), membranous glomerulonephritis (MGN),
and focal segmental glomerulosclerosis (FSGS). Abnormal intrarenal oxygenation patterns and consequent hypoxia associated with primary nephrotic syndrome have spurred
investigations into BOLD MRI’s use in these disorders.
As mentioned, medullary R2* values in BOLD MRI are used as a marker for medullary
oxygen concentration, with several studies correlating lower mR2* values with primary
nephrotic syndrome progression. Recent research showed that patients with various causes
of primary nephrotic syndrome had significantly lower mR2* values compared to controls.
Their mR2* values were also negatively correlated with estimated glomerular filtration rate
(eGFR) and positively correlated with tubulointerstitial lesions [11]. The significantly lower
mR2* seen in PNS patients may be secondary to reduced sodium reabsorption, and thus,
reduced oxygen consumption, as well as enhanced oxyhemoglobin concentrations within
inflammatory and immune-mediated kidney injuries [11–13]. Furthermore, correlations of
mR2* with eGFR highlight the potential for BOLD MRI to be used clinically in PNS patients
to evaluate their kidney function and prognosis [11,14].
Another recent study showed that higher cR2* values correlated positively with hypoxia and renal impairment in a sample of 29 patients with CKD, 9 of whom had underlying
membranous glomerulonephritis [5]. Given that these findings were in CKD patients, of
whom a large proportion had membranous glomerulonephritis, further investigation into
an isolated patient population of those with MGN or other PNS is warranted. Such studies
would help to support the use of BOLD MRI in the clinical setting for monitoring renal
function in patients with PNS.
3. Nephrotic Syndrome Secondary to Diabetes Mellitus
Uncontrolled diabetes mellitus can lead to diabetic nephropathy (DN), which can
later present as a secondary nephrotic syndrome. Development of nephrotic syndrome
in diabetic patients involves multiple mechanisms and signaling pathways, including
increased extracellular matrix deposition at the glomerular basement membrane. Longstanding diabetic nephropathy can lead to persistent albuminuria that depletes serum
albumin, leading to edema and other classical symptoms of nephrotic syndrome [15]. The
increased prevalence of secondary nephrotic syndrome due to diabetes has made screening
for DN imperative. Testing for microalbuminuria has been a commonly used screening test
in diabetic patients, but several studies have demonstrated that microalbuminuria often
resolves in early stage DN patients and may not be an accurate biomarker [16–18]. While
the introduction of contiguous tests, such as albumin to creatinine ratios, has attempted
to increase the accuracy of screening and diagnosis, there is still room for innovation in
this constantly developing area. Such potential makes BOLD MRI a highly attractive
noninvasive alternative to evaluate DN progression.
To this end, several studies have attempted to correlate BOLD MRI results with
DN progression in order to monitor the disease before its development to nephrotic
syndrome (Figure 2). One BOLD MRI study found that mR2* values were highest in
diabetic patients with normoalbuminuria when compared to healthy patients and diabetic
patients with microalbuminuria, suggesting that medullary hypoxia may resolve with DN
progression [19]. These results are in contrast to another study by Wang et al., which found
that mR2* values in DN patients were significantly lower than those in healthy patients
(Figure 2) [20]. This discrepancy may be explained by the fact that advanced DN reduces the
glomerular filtration rate, in turn decreasing sodium transport and renal oxygen usage [20].
A higher kidney oxygenation (lower mR2* values) occurs as a result, which may reconcile
with the lower mR2* values found in Feng et al.’s moderately microalbuminuric patients.
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5. Discussion
Although BOLD MRI was initially used for cerebrovascular imaging, its use in other
organ systems is being increasingly explored. Recent literature demonstrates that BOLD
MRI of the kidney has significant potential for clinical and research use (Table 1). Not
only is the technology noninvasive, but it also allows clinicians to image and functionally understand renal blood flow and oxygenation without using contrast or radiation.
Here, we explored advances made in understanding the technology underlying BOLD
MRI for renal studies as well as for its potential diagnostic and clinical role in several
nephrotic and nephritic syndromes. For diabetic patients, several studies used BOLD MRI
to evaluate diabetic nephropathy progression, but the correlation of R2* values with DN
stages yielded mixed results. Two studies that evaluated the effect of diabetic nephropathy
treatment on BOLD MRI values differed, finding that lipo-prostaglandin E1 decreased
mR2* levels, but that RAAS-modulating drugs did not [21,22]. These inconclusive results
demonstrate that more BOLD MRI studies on diabetic nephropathy are needed. In regard to primary nephrotic syndrome, early research is supportive of BOLD MRI’s clinical
use, although further research that evaluates each nephrotic syndrome individually (e.g.,
MGN) is needed, rather than summative analyses. Given the association of nephrotic
syndrome with renal hypoxia and BOLD MRI’s utility in assessing intrarenal oxygenation,
this technology may serve a role in determining a patient-specific prognosis as well as
evaluating progression for those with PNS. Investigations into the utility of using BOLD
MRI in nephritic syndrome secondary to lupus nephritis showed promise, as two recent
studies found consistent and statistically significant correlations in the ability of BOLD
MRI to detect tubulointerstitial pathology in LN patients. This raises the possibility of
using the technology to track progression of tubulointerstitial lesions, or even playing a
role in establishing the diagnosis. As prognosis and disease physiology in LN can widely
differ based on ISN/RPS classification, studies with samples that are more proportionally
balanced in terms of disease histopathology are needed to increase validity.
Table 1. Summary of BOLD MRI studies. MG = membranous glomerulonephritis, PNS = primary nephrotic syndrome,
DN = diabetic nephropathy, LN = lupus nephritis, NAU = normal to mildly increased albuminuria, MAU = moderately
increased albuminuria, TR = repetition time, TE = echo time.

Author
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Design

Population

TR (ms)/
TE (ms)
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eGFR
(mL/min/1.73 m2 )
(Patients,
Volunteers)
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(sec−1 )
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mR2 *
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Statistical
Analysis
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–
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Pearson
correlation,
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Prospective
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–
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coefficient,
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Feng et al.
[19]

Wang et al.
[20]

Li et al. [21]

Pruijm et al.
[22]

2018

2013

Prospective
case-control
Prospective
randomized
two-way
crossover
study

30 DN
patients,
15 healthy
volunteers

23.3 ± 6.5, -b

17.9 ± 1.5, –
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Table 1. Cont.

Author

Year

Design

Population

TR (ms)/
TE (ms)

Disease
Stage

eGFR
(mL/min/1.73 m2 )
(Patients,
Volunteers)

cR2*
(sec−1 )
(Patients,
Volunteers)

mR2 *
(sec−1 )
(Patients,
Volunteers)

Statistical
Analysis

Li et al. [25]

2014

Retrospective
case-control

65 LN
patients,
16 healthy
volunteers

110/2.2–27.5

Class I–V

–

11.0 ± 1.6,
12.6 ± 1.4

14.1 ± 3.4,
18.1 ± 2.5

Pearson
correlation,
t-test

Rapacchi
et al. [26]

2015

Retrospective
case-control

10 LN
patients,
10 healthy
volunteers

187/2.2–43.7

Class III–V

104.7 ± 38.3,
88.3 ± 13.1

–

–

Stepwise
logistic
regression,
unpaired
t-test

Shi et al. [27]

2017

Retrospective
case-control

23 LN
patients,
10 healthy
volunteers

100/2.4–29

Class III–V

102.7 ± 24.8,
112.2 ± 18.8

–

–

Multiple correspondence,
ANOVA

a MAU values. NAU values are as follows: estimated glomerular filtration rate (eGFR) 102.02 ± 17.80 (mL/min/1.73m2 ), cR2* 16.43 ± 2.12
(msec−1 ), mR2 * 34.61 ± 3.39 (msec−1 ). b (msec−1 ).

Considering that lesions in the glomeruli are primarily in the renal cortex, monitoring
changes in cR2* values may appear more appropriate for BOLD imaging of glomerular
diseases. However, most studies report a greater statistical significance between mR2*
values and disease state compared to cR2* values and disease state. This may be explained
by two reasons: The renal medulla receives less blood perfusion compared to the renal
cortex, and sodium transporters in the renal medulla exert a high metabolic demand.
Pathologic decreases in blood perfusion may result in a lower blood oxygen content, which
is exacerbated by high oxygen consumption occurring in the medullary collecting ducts.
While the lesions in nephrotic and nephritic syndrome are primarily in the cortex, there
may be a pathologic downstream translation to the medulla, which could explain the high
medullary signal in the presented data.
Although many of the reported studies are promising, it is important to address
several limitations. First, BOLD MRI signals can be affected by factors such as temperature
and pH. For example, increased temperature increases oxygen offloading, shifting the
oxygenation dissociation curve to the right and causing changes in BOLD signal intensity,
independent of perfusion. These distinct influences on oxygen offloading can complicate
attempts to associate renal perfusion and BOLD MRI signals [9]. Furthermore, oxygenation,
blood flow, sodium transport, and hydration status are all interdependent and any external
or internal factors that influence those variables can create noise that interferes with BOLD
signals. It is important that these variables are controlled as best as possible prior to
proceeding with BOLD MRI, in both research studies and the clinic, for the standardization
of results [8,29,30]. Non-oxygenation-related interference factors within BOLD MRI must
also be addressed. For example, BOLD signal loss has been documented in neuroimaging,
stemming from metal implants such as intracortical electrodes [31]. In renal imaging, the
presence of nephrolithiasis or hip arthroplasty can limit visualization of target lesions.
Additionally, motion artifacts such as body movement, physiologic noise (such as pulsatile
cerebrospinal fluid and arterial blood), and instrumentation noise from scanners can cause
interference with BOLD signals [31,32].
MRIs are also expensive and time consuming, limiting the number of participants
enrolled in studies [5,11,26,27,29,33,34]. Larger sample sizes are necessary to validate
whether BOLD MRI is truly effective in the clinical assessment of renal function in patients
with glomerular disease; one study also recommended the use of multicenter randomized
controlled trials for external validity of the usage of BOLD MRI [33]. Variability and
limitations in imaging techniques within BOLD MRI also limit the internal validity. For
example, ROI analysis is commonly used, but is known to have relatively poor levels of
inter-observer reliability. Furthermore, in advanced stages of glomerular diseases, the renal
cortex and medulla are often difficult to visually distinguish, impairing visualization of the
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ROI. The use of the TLCO technique has been shown to produce a higher sensitivity and
specificity for BOLD imaging in advanced kidney diseases compared to ROI [35].
In conclusion, BOLD MRI has shown promising early results for potential use in
clinical practice. While the technology has significant limitations that must be considered,
numerous studies have shown encouraging findings that should be further investigated.
These advancements in BOLD MRI have the potential to significantly change diagnosis,
monitoring, and long-term outcomes of patients with glomerular disease.
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Abbreviations
BOLD MRI
CKD
DN
eGFR
ISN/RPS
LN
mGRE
PNS
ROI
TLCO

Blood oxygen level-dependent magnetic resonance imaging
Chronic kidney disease
Diabetic nephropathy
Estimated glomerular filtration rate
International Society of Nephrology/Renal Pathology Society
Lupus nephritis
Multiple gradient-recalled-echo
Primary nephrotic syndrome
Region of interest
Twelve-layer concentric objects
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